Source comparison
AOD-9604 vs MOTS-c — Peptide Mechanisms Compared
Research published in the Journal of Molecular Endocrinology found that AOD-9604. A 15-amino-acid C-terminal fragment of human growth hormone. Retained the lipolytic activity of the parent molecule without stimulating IGF-1 production or affecting glucose meta
This comparison does not assign a generated winner or score.
- Research published in the Journal of Molecular Endocrinology found that AOD-9604. A 15-amino-acid C-terminal fragment of human growth hormone. Retained the lipolytic activity of the parent molecule without stimulating IGF-1 production or affecting glucose metabolism. MOTS-c, by contrast, is a mitochondrial-derived peptide encoded by the 12S rRNA gene that acts as a metabolic regulator by translocating to the nucleus under glucose stress and modulating insulin sensitivity through AMPK activation. The difference between AOD-9604 and MOTS-c runs deeper than application. It's a structural vs regulatory distinction.
- We've analyzed hundreds of peptide research protocols across metabolic studies. The confusion between these two compounds stems from oversimplified marketing claims that both 'support fat loss'. But the mechanisms, endpoints, and研究 contexts are fundamentally different.
- What's the difference between AOD-9604 and MOTS-c?
- AOD-9604 is a synthetic peptide fragment (amino acids 176–191 of hGH) that stimulates lipolysis through beta-3 adrenergic receptor activation without affecting cell proliferation or insulin response. MOTS-c is a mitochondrial-encoded regulatory peptide that improves glucose uptake, enhances insulin sensitivity via AMPK and GLUT4 pathways, and crosses the blood-brain barrier to influence hypothalamic metabolic signaling. Making it a systemic metabolic regulator rather than a localized lipolytic agent.
- The difference between AOD-9604 and MOTS-c isn't just where they act. It's what they do once they get there. AOD-9604 binds to beta-3 adrenergic receptors on adipocyte surfaces, triggering hormone-sensitive lipase (HSL) to break down stored triglycerides into free fatty acids and glycerol. MOTS-c enters cells, translocates to mitochondria, and modulates the expression of nuclear-encoded metabolic genes. Influencing how cells process glucose at the insulin receptor level. One targets fat stores directly; the other reprograms cellular fuel partitioning.